Pregled bibliografske jedinice broj: 1042554
Development, characterisation and nasal deposition of melatonin-loaded pectin/hypromellose microspheres
Development, characterisation and nasal deposition of melatonin-loaded pectin/hypromellose microspheres // European journal of pharmaceutical sciences, 141 (2020), 105-115 doi:10.1016/j.ejps.2019.105115 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1042554 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Development, characterisation and nasal deposition of melatonin-loaded pectin/hypromellose microspheres
Autori
Nižić, Laura ; Potaś, Joanna ; Winnicka, Katarzyna ; Szekalska, Marta ; Erak, Iva ; Gretić, Matija ; Jug, Mario ; Hafner, Anita
Izvornik
European journal of pharmaceutical sciences (0928-0987) 141
(2020);
105-115
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
melatonin ; pectin ; hypromellose ; microspheres ; spray-drying ; nasal deposition
Sažetak
In this study, we present the development of spray-dried pectin/hypromellose microspheres as efficient melatonin carrier for targeted nasal delivery. Different pectin to hypromellose weight ratios in the spray-dried feed were employed (i.e. 1:0, 3:1, 1:1 and 1:3) in order to optimise microsphere physicochemical properties influencing overall powder behaviour prior, during and upon nasal delivery. All microspheres assured complete melatonin entrapment and increased dissolution rate in relation to pure melatonin powder. Among all combinations tested, combining pectin with hypromellose at 1:3 wt ratio resulted in the microspheres with the highest potential for melatonin nasal delivery as they assured highest swelling ability and most prominent mucoadhesive properties. Studies on deposition profile revealed adequate turbinate and olfactory deposition of microsphere/lactose monohydrate powder blend administered nasally using MIAT® device, complementing findings relevant for their therapeutic potential. In conclusion, developed microspheres bear the potential to ensure prolonged melatonin retention at the nasal mucosa, improved bioavailability and advanced therapeutic outcome.
Izvorni jezik
Engleski
Znanstvena područja
Farmacija
POVEZANOST RADA
Projekti:
HRZZ-UIP-2017-05-4592 - Optimiranje depozicije raspršenih in situ gelirajućih i praškastih terapijskih sustava u nosnoj šupljini (OptiNasalSpray) (Hafner, Anita, HRZZ - 2017-05) ( CroRIS)
Ustanove:
Farmaceutsko-biokemijski fakultet, Zagreb,
Fakultet kemijskog inženjerstva i tehnologije, Zagreb,
PLIVA HRVATSKA d.o.o.
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE